Advertisement

Advertisement

Quick Chats

hematologic malignancies
immunotherapy

By The ASCO Post Staff  / Quick Chats

Andrew D. Zelenetz, MD, PhD, and Stephen J. Schuster, MD, on CAR T Cells for Hematologic Malignancies: Where We’re At

multiple myeloma

By The ASCO Post Staff  / Quick Chats

Paul G. Richardson, MD, and Peter M. Voorhees, MD, on Multiple Myeloma: Surveying the Evolving Landscape of Up-Front Drugs

colorectal cancer
gastrointestinal cancer

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Liquid Biopsies for Colorectal and Other GI Cancers

colorectal cancer
genomics/genetics

By The ASCO Post Staff  / Quick Chats

Heinz-Josef Lenz, MD, and Axel Grothey, MD, on Colorectal Cancer: Molecular Testing and Interpreting an NGS Report

Advertisement

Advertisement



Dec
02
Today In Oncology
Regular Screening Mammograms May Significantly Reduce Breast Cancer Mortality, Swedish Study Shows
Toxicities Potentially Linked to Combination Immunotherapy for Mesothelioma
Colorectal Cancer Incidence and Time to Recurrence
Risk-Adapted Radioimmunotherapy for Locally Advanced PD-L1–Positive NSCLC
Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors
View More 
Advertisement
© 2023 HSP News Service, L.L.C.
Designed by Harborside